| [1] Gaharwar AK, Patel A, Dolatshahi-Pirouz A, et al. Elastomeric nanocomposite scaffolds made from poly (glycerol sebacate) chemically crosslinked with carbon nanotubes. Biomater Sci. 2015;3(1):45-68.[2] Pawar K, Cummings BJ, Thomas A, et al. Biomaterial bridges enable regeneration and re-entry of corticospinal tract axons into the caudal spinal cord after SCI: association with recovery of forelimb function. Biomaterials. 2015;65:1-12.[3] Siciliano C, Chimenti I, Ibrahim M, et al. Cardiosphere conditioned media influence the plasticity of human mediastinal adipose tissue-derived mesenchymal stem cells. Cell Transplant. 2015;24(11):2307-2322. [4] Li Y, Tang J, Hu Y, et al. A study of autologous stem cells therapy assisted regeneration of cartilage in avascular bone necrosis. Eur Rev Med Pharmacol Sci. 2015;19(20):3833-3837.[5] Selle F, Pautier P, Lhommé C, et al. A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: the ITOV 01bis Study. Chemotherapy. 2015;61(1):15-22. [6] Richter R, Rüster B, Bistrian R, et al. Beta-chemokine CCL15 affects the adhesion and migration of hematopoietic progenitor cells. Transfus Med Hemother. 2015;42(1):29-37. [7] He H, Zhao ZH, Han FS, et al. Activation of protein kinase C ε enhanced movement ability and paracrine function of rat bone marrow mesenchymal stem cells partly at least independent of SDF-1/CXCR4 axis and PI3K/AKT pathway. Int J Clin Exp Med. 2015;8(1): 188-202. [8] Adamiak M, Borkowska S, Wysoczynski M, et al. Evidence for the involvement of sphingosine- 1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow. Oncotarget. 2015;6(22):18819-18828.[9] Li N, Yang YJ, Qian HY, et al.Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. Am J Transl Res. 2015;7(6):1058-1070. [10] Cheng M, Huang K, Zhou J, et al. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart. J Mol Cell Cardiol. 2015;81:49-53.[11] Machalińska A, K?os P, Baumert B, et al. Stem Cells are mobilized from the bone marrow into the peripheral circulation in response to retinal pigment epithelium damage-a pathophysiological attempt to induce endogenous regeneration. Curr Eye Res. 2011; 36(7): 663-672. [12] Yuan S, Fan G. Stem cell-based therapy of corneal epithelial and endothelial diseases. Regen Med. 2015; 10(4):495-504.[13] Rocca CJ, Kreymerman A, Ur SN, et al. Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation. Invest Ophthalmol Vis Sci. 2015; 56(12):7214-7223. [14] Gundogan FC, Kocak N, Akyildiz R, et al. The prevalence and causes of visual impairment in young Turkish men. Pak J Med Sci. 2015;31(4):837-842. [15] Adhikari S, Shrestha MK, Adhikari K, et al. Causes of visual impairment and blindness in children in three ecological regions of nepal: nepal pediatric ocular diseases study. Clin Ophthalmol. 2015;9:1543- 1547.[16] Yuan S, Fan G. Stem cell-based therapy of corneal epithelial and endothelial diseases. Regen Med. 2015; 10(4):495-504. [17] Navaratnam J, Utheim TP, Rajasekhar VK, et al. Substrates for expansion of corneal endothelial cells towards bioengineering of human corneal endothelium. J Funct Biomater. 2015;6(3):917-945. [18] Levis HJ, Kureshi AK, Massie I, et al. Tissue engineering the cornea: the evolution of RAFT. J Funct Biomater. 2015;6(1):50-65. [19] Muhammad R, Peh GS, Adnan K,et al. Micro- and nano-topography to enhance proliferation and sustain functional markers of donor-derived primary human corneal endothelial cells. Acta Biomater. 2015;19: 138-148. [20] Avadhanam VS, Liu CS. A brief review of Boston type-1 and osteo-odonto keratoprostheses. Br J Ophthalmol. 2015;99(7):878-887.[21] Yuan S, Fan G. Stem cell-based therapy of corneal epithelial and endothelial diseases. Regen Med. 2015;10(4):495-504.[22] Holan V, Trosan P, Cejka C, et al. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction. Stem Cells Transl Med. 2015;4(9):1052-1063.[23] Zhao H, Qu M, Wang Y, et al. Xenogeneic acellular conjunctiva matrix as a scaffold of tissue-engineered corneal epithelium. PLoS One. 2014;9(11):e111846.[24] Barreiro TP, Santos MS, Vieira AC, et al. Comparative study of conjunctival limbal transplantation not associated with the use of amniotic membrane transplantation for treatment of total limbal deficiency secondary to chemical injury. Cornea. 2014;33(7): 716-720. [25] Petsch C, Schlötzer-Schrehardt U, Meyer-Blazejewska E, et al. Novel collagen membranes for the reconstruction of the corneal surface. Tissue Eng Part A. 2014;20(17-18):2378-2389. [26] Jeon S, Choi SH, Wolosin JM, et al. Regeneration of the corneal epithelium with conjunctival epithelial equivalents generated in serum- and feeder-cell-free media. Mol Vis. 2013;19:2542-2550.[27] Brown KD, Low S, Mariappan I, et al. Plasma polymer-coated contact lenses for the culture and transfer of corneal epithelial cells in the treatment of limbal stem cell deficiency. Tissue Eng Part A. 2014; 20(3-4):646-655. [28] Yin JQ, Liu WQ, Liu C, et al. Reconstruction of damaged corneal epithelium using Venus-labeled limbal epithelial stem cells and tracking of surviving donor cells. Exp Eye Res. 2013;115:246-254. [29] Zhang W, Yang W, Liu X, et al. Rapidly constructed scaffold-free embryonic stem cell sheets for ocular surface reconstruction. Scanning. 2014;36(3):286-292. [30] Holan V, Javorkova E. Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction. Stem Cell Rev. 2013;9(5):609-619. [31] Ho TC, Chen SL, Wu JY, et al. PEDF promotes self-renewal of limbal stem cell and accelerates corneal epithelial wound healing. Stem Cells. 2013; 31(9):1775-1784. [32] Levis HJ, Kureshi AK, Massie I, et al. Tissue engineering the cornea: the evolution of RAFT. J Funct Biomater. 2015;6(1):50-65. [33] Casaroli-Marano RP, Nieto-Nicolau N, Martínez- Conesa EM, et al. Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular Surface. J Clin Med. 2015;4(2):318-342. [34] Zhao Y, Ma L. Systematic review and meta-analysis on transplantation of ex vivo cultivated limbal epithelial stem cell on amniotic membrane in limbal stem cell deficiency. Cornea. 2015;34(5):592-600. [35] Huang M, Wang B, Wan P, et al. Roles of limbal microvascular net and limbal stroma in regulating maintenance of limbal epithelial stem cells. Cell Tissue Res. 2015;359(2):547-563. [36] Ratajczak MZ. A novel view of the adult bone marrow stemcell hierarchy and stemcell trafficking. Leukemia. 2015;29(4):776-782. [37] Aiuti A, Webb IJ, Bleul C, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185(1):111-120.[38] Jo DY, Rafii S, Hamada T, et al. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000;105(1): 101-111.[39] Machalińska A, K?os P, Baumert B, et al. Stem Cells are mobilized from the bone marrow into the peripheral circulation in response to retinal pigment epithelium damage-a pathophysiological attempt to induce endogenous regeneration. Curr Eye Res. 2011;36(7): 663-672.[40] Li Y, Reca RG, Atmaca-Sonmez P, et al. Retinal pigment epithelium damage enhances expression of chemoattractants and migration of bone marrow- derived stem cells. Invest Ophthalmol Vis Sci. 2006; 47(4):1646-1652. |
.jpg)
.jpg)